{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:42:15Z","timestamp":1791103335093,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.ejim.2008.07.030","type":"journal-article","created":{"date-parts":[[2008,9,3]],"date-time":"2008-09-03T20:12:06Z","timestamp":1220472726000},"page":"208-212","source":"Crossref","is-referenced-by-count":32,"title":["Epidemiological and clinical features of giant cell arteritis in Tunisia"],"prefix":"10.1016","volume":"20","author":[{"given":"Mabrouk","family":"Khalifa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Karmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nairouz Ghannouchi","family":"Jaafoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoufel","family":"Kaabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel Omezzine","family":"Letaief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fethi","family":"Bahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2008.07.030_bib1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0889-857X(05)70232-5","article-title":"Epidemiology of the vasculitides","volume":"27","author":"Gonzalez-Gay","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.ejim.2008.07.030_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00002281-200201000-00002","article-title":"Giant cell arteritis","volume":"14","author":"Levine","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ejim.2008.07.030_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2008.07.030_bib4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/pmj.79.935.511","article-title":"Giant cell arteritis","volume":"79","author":"Calvo-Romero","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ejim.2008.07.030_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-139-6-200309160-00015","article-title":"Giant-cell arteritis and polymyalgia rheumatica","volume":"139","author":"Weyand","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2008.07.030_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1444-0938.2002.tb03068.x","article-title":"Giant cell arteritis","volume":"85","author":"Gurwood","year":"2002","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.ejim.2008.07.030_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-8703(80)90285-9","article-title":"Giant cell (cranial) arteritis: a clinical review","volume":"100","author":"Huston","year":"1980","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2008.07.030_bib8","series-title":"Maladies et syndromes syst\u00e9miques, M\u00e9d\u00e9cine-Sciences Fammarion","first-page":"659","article-title":"Maladie de Horton","author":"Khan","year":"2000"},{"key":"10.1016\/j.ejim.2008.07.030_bib9","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2008.07.030_bib10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-123-3-199508010-00006","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern","volume":"123","author":"Salvarani","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2008.07.030_bib11","first-page":"273","article-title":"Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984\u20131988","volume":"19","author":"Franzen","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2008.07.030_bib12","first-page":"351","article-title":"High incidence of polymyalgia rheumatica and giant cell arteritis in a Swedish community","volume":"9","author":"Noltorp","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2008.07.030_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/art.1780340313","article-title":"Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy","volume":"34","author":"Salvarani","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2008.07.030_bib14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/ard.60.4.367","article-title":"Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18\u00a0year period","volume":"60","author":"Gonzalez-Gay","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2008.07.030_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.md.0000180043.19285.54","article-title":"Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2008.07.030_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-88-2-162","article-title":"Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study","volume":"88","author":"Huston","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2008.07.030_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/md.0b013e31803d1764","article-title":"Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study","volume":"86","author":"Gonzalez-Gay","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2008.07.030_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.md.0000180042.42156.d1","article-title":"Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2008.07.030_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients","volume":"111","author":"Liozon","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2008.07.030_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejim.2005.02.001","article-title":"Silent versus cranial giant cell arteritis. Initial presentation and outcome of 50 biopsy-proven cases","volume":"16","author":"Hamidou","year":"2005","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2008.07.030_bib21","first-page":"1272","article-title":"Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course","volume":"30","author":"Liozon","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2008.07.030_bib22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.20231","article-title":"Giant cell arteritis without clinically evident vascular involvement in a defined population","volume":"51","author":"Gonzalez-Gay","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2008.07.030_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis. Trends and clinical spectrum in161 patients","volume":"79","author":"Gonzalez-Gay","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2008.07.030_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ejim.2008.07.030_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00055735-199812000-00013","article-title":"Ocular manifestations of giant cell arteritis","volume":"9","author":"Tovilla-Canales","year":"1998","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ejim.2008.07.030_bib26","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","article-title":"Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment","volume":"41","author":"Gonzalez-Gay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2008.07.030_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/1529-0131(200104)45:2<140::AID-ANR166>3.0.CO;2-2","article-title":"Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study","volume":"45","author":"Salvarani","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2008.07.030_bib28","first-page":"73","article-title":"Giant cell arteritis with an erythrocyte sedimentation rate lower than 50","volume":"19","author":"Martinez-Taboada","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2008.07.030_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/art.1780340214","article-title":"Temporal arteritis with normal erythrocyte sedimentation rates presenting as occipital neuralgia","volume":"34","author":"Jundt","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2008.07.030_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/jcp.53.2.131","article-title":"Temporal artery biopsy: is there any value in examining biopsies at multiple levels?","volume":"53","author":"Chakrabarty","year":"2000","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejim.2008.07.030_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/bmj.315.7107.549","article-title":"Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Sensitivity of temporal artery biopsy varies with biopsy length and sectioning strategy","volume":"315","author":"Sudlow","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2008.07.030_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/sarh.2001.16650","article-title":"Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy","volume":"30","author":"Gonzalez-Gay","year":"2001","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ejim.2008.07.030_bib33","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199711063371902","article-title":"Color duplex ultrasonography in the diagnosis of temporal arteritis","volume":"337","author":"Schmidt","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2008.07.030_bib34","first-page":"S43","article-title":"Imaging findings in extracranial temporal arteritis","volume":"18","author":"Stanson","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2008.07.030_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00002281-200101000-00007","article-title":"Magnetic resonance imaging of large vessel vasculitis","volume":"13","author":"Ataly","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ejim.2008.07.030_bib36","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/bjo.85.9.1061","article-title":"Steroid management in giant cell arteritis","volume":"85","author":"Chan","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ejim.2008.07.030_bib37","first-page":"S58","article-title":"Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives","volume":"18","author":"Ferraccioli","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2008.07.030_bib38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/ard.47.9.733","article-title":"Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of Prognostic features and different corticosteroid regimens (11\u00a0year survey of 210 patients)","volume":"47","author":"Delecoeuillerie","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2008.07.030_bib39","first-page":"1186","article-title":"The diagnosis and management of patients with giant cell arteritis","volume":"32","author":"Gonzalez-Gay","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejim.2008.07.030_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","article-title":"Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial","volume":"134","author":"Jover","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2008.07.030_bib41","first-page":"303","article-title":"Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: a retrospective study","volume":"15","author":"Nesher","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2008.07.030_bib42","first-page":"1283","article-title":"Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients","volume":"21","author":"Nesher","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2008.07.030_bib43","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.11353","article-title":"Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50\u00a0years","volume":"48","author":"Nuenninghoff","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2008.07.030_bib44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.md.0000145366.40805.f8","article-title":"Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine (Baltimore)"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508002045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508002045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T04:57:39Z","timestamp":1545800259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620508002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0953620508002045"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2008.07.030","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}